Log in
Enquire now
Hemab

Hemab

Hemab Therapeutics is pioneering the first preventative treatments for rare bleeding and thrombotic disorders to ensure no patient is ever left behind

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
CEO
‌
Benny Sorensen
CFO
‌
Mads Behrndt
Legal Name
Hemab ApS
Company Operating Status
Active
COO
‌
Anant Murthy
Country
Denmark
Denmark
Crunchbase URL
crunchbase.com/organiz...on/hemab
Email Address
info@hemab.com
Founded Date
2019
Headquarters
Copenhagen
Copenhagen
Industry
‌
Deep Tech
‌
Rare disease
Biotechnology
Biotechnology
Biology
Biology
Pharmaceutical industry
Pharmaceutical industry
Technology
Technology
Health technology
Health technology
Investors
Avoro Ventures
Avoro Ventures
HealthCap
HealthCap
‌
Novo A/S
Rock Springs Capital
Rock Springs Capital
Sofinnova Partners
Sofinnova Partners
Invus
Invus
RA Capital Management
RA Capital Management
Access Biotechnology
Access Biotechnology
Joe Anderson
Joe Anderson
Novo Holdings
Novo Holdings
•••
Latest Funding Round Date
October 27, 2025
Latest Funding Round Amount (USD)
157,000,000
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/hemabaps
Location
Copenhagen
Copenhagen
Boston
Boston
Denmark
Denmark
Number of Employees (Ranges)
11 – 50
0
Phone Number
+12313146867
Total Funding Amount (USD)
407,000,000
Twitter URL
@hemab_tx
Official Website
hemab.com

Find more companies like Hemab

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us